| C-reactive protein, inflammation, and coronary risk DA Morrow, PM Ridker Medical Clinics of North America 84 (1), 149-161, 2000 | 316 | 2000 |
| Factor V Leiden mutation as a risk factor for recurrent pregnancy loss PM Ridker, JP Miletich, JE Buring, AA Ariyo, DT Price, JAE Manson, ... Annals of internal medicine 128 (12_Part_1), 1000-1003, 1998 | 315 | 1998 |
| C-reactive protein comes of age S Verma, PE Szmitko, PM Ridker Nature Clinical Practice Cardiovascular Medicine 2 (1), 29-36, 2005 | 313 | 2005 |
| Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes BM Everett, MY Donath, AD Pradhan, T Thuren, P Pais, JC Nicolau, ... Journal of the American College of Cardiology 71 (21), 2392-2401, 2018 | 312 | 2018 |
| Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol< 50 mg/dl with rosuvastatin: the JUPITER trial (Justification for … J Hsia, JG MacFadyen, J Monyak, PM Ridker Journal of the American College of Cardiology 57 (16), 1666-1675, 2011 | 312 | 2011 |
| Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)—can C-reactive protein be used to target statin therapy in … S Mora, PM Ridker The American journal of cardiology 97 (2), 33-41, 2006 | 305 | 2006 |
| Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism Y Sapkota, V Steinthorsdottir, AP Morris, A Fassbender, N Rahmioglu, ... Nature communications 8 (1), 15539, 2017 | 304 | 2017 |
| Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease MMG McDermott, JM Guralnik, P Greenland, WH Pearce, MH Criqui, K Liu, ... Circulation 107 (5), 757-761, 2003 | 304 | 2003 |
| Genome-wide analysis identifies 12 loci influencing human reproductive behavior N Barban, R Jansen, R De Vlaming, A Vaez, JJ Mandemakers, FC Tropf, ... Nature genetics 48 (12), 1462-1472, 2016 | 303 | 2016 |
| Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism M Germain, DI Chasman, H De Haan, W Tang, S Lindström, LC Weng, ... The American Journal of Human Genetics 96 (4), 532-542, 2015 | 303 | 2015 |
| Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21. 3 NP Paynter, DI Chasman, JE Buring, D Shiffman, NR Cook, PM Ridker Annals of internal medicine 150 (2), 65-72, 2009 | 303 | 2009 |
| Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis Emerging Risk Factors Collaboration International journal of epidemiology 41 (5), 1419-1433, 2012 | 302 | 2012 |
| Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis RYL Zee, PM Ridker Atherosclerosis 162 (1), 217-219, 2002 | 299 | 2002 |
| HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial PM Ridker, J Genest, SM Boekholdt, P Libby, AM Gotto, BG Nordestgaard, ... The Lancet 376 (9738), 333-339, 2010 | 298 | 2010 |
| Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a … RJ Glynn, W Koenig, BG Nordestgaard, J Shepherd, PM Ridker Annals of internal medicine 152 (8), 488-496, 2010 | 292 | 2010 |
| Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men AD Pradhan, N Rifai, PM Ridker Circulation 106 (7), 820-825, 2002 | 291 | 2002 |
| Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption MC Cornelis, EM Byrne, T Esko, MA Nalls, A Ganna, N Paynter, ... Molecular psychiatry 20 (5), 647-656, 2015 | 290 | 2015 |
| C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease PM Ridker Clinical chemistry 55 (2), 209-215, 2009 | 288 | 2009 |
| Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians CJ O'Donnell, PM Ridker, RJ Glynn, K Berger, U Ajani, JAE Manson, ... Circulation 95 (5), 1132-1137, 1997 | 288 | 1997 |
| Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins I Postmus, S Trompet, HA Deshmukh, MR Barnes, X Li, HR Warren, ... Nature communications 5 (1), 5068, 2014 | 287 | 2014 |
